semaglutide and lipo injections Weight Loss & Nutrition Management Semaglutide: A Weight Loss Solution

Tirzepatide Approvals: Glycemic control for those with type 2 diabetes

Cell 15, 10551064

Product information provided by manufacturer and is subject to change

Participants Adults (18 years old) with 1 or more self-reported unsuccessful dietary weight loss efforts and a body mass index (BMI, calculated as weight in kilograms divided by height in meters squared) of 30 or greater or 27 or greater with 1 or more weight-related comorbidities (hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease) were eligible (eAppendix 1 in Supplement 3)

TRIUMPH-3 will specifically investigate the use of retatrutide in obese patients with established cardiovascular disease